There are a couple of ESPR articles out today. Somehow, I don't think that this is the one that is driving the stock's surge.
August 8, 2017
Esperion Therapeutics reports 2Q loss
Associated Press Associated Press
ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $43.3 million in its second quarter.
The Ann Arbor, Michigan-based company said it had a loss of $1.92 per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.67 per share.
Esperion Therapeutics shares have more than tripled since the beginning of the year. The stock has more than quadrupled in the last 12 months.
Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months